Phone: +86-18519734165
Email: info@assointernationalconsulting.com
Opening:
Get a Quote

About ASSO International Consulting

ASSO regards each project as the best communication bridge between us and our customers. ASSO solemnly promises that ASSO will treat each project as our most important customer project.

Important Links

  • ASSO
  • 2021-08-21
  • comments

Global Transdermal Drug Patches Strategic Research Report

Global Transdermal Drug Patches Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
 
The major players in global market include
    Noven
    Mylan
    Novartis
    Johnson & Johnson
    Agile Therapeutics
    Teikoku Pharma USA
    Immune Pharmaceuticals
    Hercon Pharmaceuticals
    Pocono
    DURECT Corporation
    Xel Pharmaceuticals
 
Geographically, this report is segmented into several key Regions, with production, consumption, revenue, market share and growth rate of Transdermal Drug Patches in these regions, from 2013 to 2024 (forecast), covering
    North America (United States,Canada, Mexico)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Other Regions )
    Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
    South America (Brazil. Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, U.A.E, Other Regions)
 
On the basis of product, the Transdermal Drug Patches market is primarily split into
    Fentanyl Transdermal Patch
    Nicotine Transdermal Patch
    Buprenorphine Transdermal Patch
    Clonidine Transdermal Patch
    Oxybutynin Transdermal Patch
    Others
 
On the basis on the end users/applications, this report covers
    Hypertension
    Contraception
    Analgesia
    Smoking Cessation
    Angina
    Hormone Replacement
 
Table of Contents
1 Target Product and Background
    1.1 Product Overview Transdermal Drug Patches
    1.2 Research Method
    1.3 Data Source
    1.4 Project Cycle
    1.5 Forecast Data Base & Factor
    1.6 Macroeconomic Development Trends
    1.7 Impact of COVID-19 on the Economy and Transdermal Drug Patches Industry
        1.7.1 Post-COVID-19 era
        1.7.2 The Impact of COVID-19 on Transdermal Drug Patches Industry
2 Manufacturers Competitive Analysis of Major Players
    2.1 Competitive Segmentation Analysis of Key Players
    2.2 2016-2021 Key Players Sales Volume and Market Positions
    2.3 Key Players Revenue and Market Positions
3 Transdermal Drug Patches Sales Segment Analysis by Type
    3.1 Overview
        3.1.1 Fentanyl Transdermal Patch
        3.1.2 Nicotine Transdermal Patch
        3.1.3 Buprenorphine Transdermal Patch
        3.1.4 Clonidine Transdermal Patch
        3.1.5 Oxybutynin Transdermal Patch
        3.1.6 Others
    3.2 2016-2027 Global Transdermal Drug Patches Sales Volume Segment Analysis by Type
    3.3 2016-2027 Global Transdermal Drug Patches Revenue Segment Analysis by Type
4 Transdermal Drug Patches Sales Segment Analysis End User
    4.1 Introduction
        4.1.1 Hypertension
        4.1.2 Contraception
        4.1.4 Smoking Cessation
        4.1.5 Angina
        4.1.6 Hormone Replacement
    4.2 2016-2027 Global Transdermal Drug Patches Sales Volume Segment Analysis by End User
    4.3 2016-2027 Global Transdermal Drug Patches Revenue Segment Analysis by End User
5 Transdermal Drug Patches Market Analysis, by Region by Country
    5.1 Global Transdermal Drug Patches Market Size and Regional Analysis
    5.2 Global Transdermal Drug Patches Retrospective Market Scenario in Revenue by Region: 2016-2021
    5.3 North America Market Size and Regional Analysis
        5.3.1 North America Sales by Country
        5.3.2 North America Transdermal Drug Patches Revenue by Country
    5.4 Europe Market Size and Regional Analysis
        5.4.1 Europe Transdermal Drug Patches Sales by Country
        5.4.2 Europe Transdermal Drug Patches Revenue by Country
    5.5 Asia Pacific Market Size and Regional Analysis
        5.5.1 Asia Pacific Transdermal Drug Patches Sales by Region
        5.5.2 Asia Pacific Transdermal Drug Patches Revenue by Region
    5.6 South America Market Size and Regional Analysis
        5.6.1 South America Transdermal Drug Patches Sales by Country
        5.6.2 South America Transdermal Drug Patches Revenue by Country
    5.7 Middle East and Africa Market Size and Regional Analysis
        5.7.1 Middle East and Africa Transdermal Drug Patches Sales by Country
        5.7.2 Middle East and Africa Transdermal Drug Patches Revenue by Country
6 Transdermal Drug Patches SWOT and Driving Factor Analysis
    6.1 SWOT Analysis
    6.2 Marketing Strategy
    6.3 Technology Driven Market
    6.4 Transdermal Drug Patches Growth Drivers
    6.5 Transdermal Drug Patches Market Challenges
    6.6 Transdermal Drug Patches Market Restraints
7 Transdermal Drug PatchesRaw Material Supply and Industry Chain Analysis
    7.1 Transdermal Drug Patches Key Raw Material Supply
        7.1.1 Key Raw Materials
        7.1.2 Key Suppliers of Raw Materials
    7.2 Transdermal Drug Patches Industrial Chain Analysis and Reconstruction
8 Global Transdermal Drug Patches Major Manufacturers Analysis
    8.1 Noven
        8.1.1 Noven Corporate Outline
        8.1.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
        8.1.3 Noven Transdermal Drug Patches  Key Product Overview
        8.1.4 Transdermal Drug Patches Key Product Overview
        8.1.5 Noven Business Segmentation SWOT Analysis
    8.2 Mylan
        8.2.1 Mylan Corporate Outline
        8.2.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
        8.2.3 Mylan Transdermal Drug Patches  Key Product Overview
        8.2.4 Transdermal Drug Patches Key Product Overview
        8.2.15Mylan Business Segmentation SWOT Analysis
    8.3 Novartis
        8.3.1 Novartis Corporate Outline
        8.3.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
        8.3.3 Xel Pharmaceuticals Transdermal Drug Patches  Key Product Overview
        8.3.4 Transdermal Drug Patches Key Product Overview
        8.3.5 Novartis Business Segmentation SWOT Analysis
    8.4 Johnson & Johnson
        8.4.1 Johnson & Johnson Corporate Outline
        8.4.1 Johnson & Johnson Corporate Outline
        8.4.3  Transdermal Drug Patches  Key Product Overview
        8.4.4 Transdermal Drug Patches Key Product Overview
        8.4.5 Johnson & Johnson Business Segmentation SWOT Analysis
    8.5 Agile Therapeutics
        8.5.1 Agile Therapeutics Corporate Outline
        8.5.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
        8.5.3  Transdermal Drug Patches  Key Product Overview
        8.5.4 Transdermal Drug Patches Key Product Overview
        8.5.5 Agile Therapeutics Business Segmentation SWOT Analysis
    8.6 Teikoku Pharma USA
        8.6.1 Teikoku Pharma USA Corporate Outline
        8.6.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
        8.6.3  Transdermal Drug Patches  Key Product Overview
        8.6.4 Transdermal Drug Patches Key Product Overview
        8.6.5 Teikoku Pharma USA Business Segmentation SWOT Analysis
    8.7 Immune Pharmaceuticals
        8.7.1 Immune Pharmaceuticals Corporate Outline
        8.7.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
        8.7.3  Transdermal Drug Patches  Key Product Overview
        8.7.4 Transdermal Drug Patches Key Product Overview
        8.7.5 Immune Pharmaceuticals Business Segmentation SWOT Analysis
    8.8 Hercon Pharmaceuticals
        8.8.1 Hercon Pharmaceuticals Corporate Outline
        8.8.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
        8.8.3  Transdermal Drug Patches  Key Product Overview
        8.8.4 Transdermal Drug Patches Key Product Overview
        8.8.5 Hercon Pharmaceuticals Business Segmentation SWOT Analysis
    8.9 Pocono
        8.9.1 Pocono Corporate Outline
        8.9.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
        8.9.3  Transdermal Drug Patches  Key Product Overview
        8.9.4 Transdermal Drug Patches Key Product Overview
        8.9.5 Pocono Business Segmentation SWOT Analysis
    8.10 DURECT Corporation
        8.10.1 DURECT Corporation Corporate Outline
        8.10.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
        8.10.3  Transdermal Drug Patches  Key Product Overview
        8.10.4 Transdermal Drug Patches Key Product Overview
        8.10.5 DURECT Corporation Business Segmentation SWOT Analysis
    8.11 Xel Pharmaceuticals
9 Transdermal Drug Patches Report Conclusion and Strategy
10 Appendix
    10.1 Order and After-sales Service
    10.2 Author List
    10.3 Disclaimer
 
List of Tables
 
Table 1. Competitive Segmentation Analysis of Key Players
Table 2. 2016-2021 Key Players Sales Volume and Market Positions (K Units)
Table 3. 2016-2021 Key Players Revenue and Market Positions (US$ Million)
Table 4. Global Transdermal Drug Patches Market Size Comparison by Type (2021-2027)
Table 5. Analysis of the Distribution of Main Players' Product Types
Table 6. 2016-2027 Global Transdermal Drug Patches Sales Volume Segment Analysis by Type (K Units)
Table 7. 2016-2027 Global Transdermal Drug Patches Sales Volume Share by Type
Table 8. 2016-2027 Global Transdermal Drug Patches Revenue Segment Analysis by Type (US$ Million)
Table 9. Global Transdermal Drug Patches Revenue Share by Type (2016-2021)
Table 10. Competitive Segmentation Analysis of Key Players
Table 11. Global Transdermal Drug Patches Market Size Comparison by End User (2021-2027)
Table 12. 2016-2027 Global Transdermal Drug Patches Sales Volume Segment Analysis by End User (K Units)
Table 13. 2016-2027 Global Transdermal Drug Patches Sales Volume Share by End User
Table 14. 2016-2027 Global Transdermal Drug Patches Revenue Segment Analysis by End User (US$ Million)
Table 15. Global Transdermal Drug Patches Revenue Share by End User (2016-2021)
Table 16. 2016-2027 Global Segment: Transdermal Drug Patches Sales Volume Market, by Region (K Units)
Table 17. 2016-2027 Global Segment: Transdermal Drug Patches Sales Volume Market Share, by Region
Table 18. 2016-2027 Global Segment: Transdermal Drug Patches Revenue Market, by Region (US$ Million)
Table 19. 2016-2027 Global Segment: Transdermal Drug Patches Revenue Market Share, by Region
Table 20. 2016-2021E North America Segment: Transdermal Drug Patches Sales Volume Market, by Country (K Units)
Table 21. 2016-2021E North America Segment: Transdermal Drug Patches Revenue Market, by Country (US$ Million)
Table 22. 2016-2021E Europe Segment: Transdermal Drug Patches Sales Volume Market, by Country (K Units)
Table 23. 2016-2021E Europe Segment: Transdermal Drug Patches Revenue Market, by Country (US$ Million)
Table 24. 2016-2021E Asia Pacific Segment: Transdermal Drug Patches Sales Volume Market, by Country (K Units)
Table 25. 2016-2021E Asia Pacific Segment: Transdermal Drug Patches Revenue Market, by Country (US$ Million)
Table 26. 2016-2021E South America Segment: Transdermal Drug Patches Sales Volume Market, by Country (K Units)
Table 27. 2016-2021E South America Segment: Transdermal Drug Patches Revenue Market, by Country (US$ Million)
Table 28. 2016-2021E Middle East and Africa Segment: Transdermal Drug Patches Sales Volume Market, by Country (K Units)
Table 29. Middle East and Africa Transdermal Drug Patches Revenue Market Share in 2020, by Country (% Share)
Table 30. 2016-2021E Middle East and Africa Segment: Transdermal Drug Patches Revenue Market, by Country (US$ Million)
Table 31. Transdermal Drug Patches Growth Drivers
Table 32. Key Suppliers of Raw Materials
Table 33. Noven Corporate Outline
Table 34. Noven Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
Table 35. Noven Key Product Overview
Table 36.  Mylan Corporate Outline
Table 37.  Mylan Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
Table 38. Mylan Key Product Overview
Table 39. Novartis Corporate Outline
Table 40. Novartis Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
Table 41. Novartis Key Product Overview
Table 42. Johnson & Johnson Corporate Outline
Table 43. Johnson & Johnson Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
Table 44. Johnson & Johnson Key Product Overview
Table 45. Agile Therapeutics Corporate Outline
Table 46. Agile Therapeutics Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
Table 47. Agile Therapeutics Key Product Overview
Table 48. Teikoku Pharma USA Corporate Outline
Table 49. Teikoku Pharma USA Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
Table 50. Teikoku Pharma USA Key Product Overview
Table 51. Immune Pharmaceuticals Corporate Outline
Table 52. Immune Pharmaceuticals Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
Table 53. Immune Pharmaceuticals Key Product Overview
Table 54. Hercon Pharmaceuticals Corporate Outline
Table 55. Hercon Pharmaceuticals Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
Table 56. Hercon Pharmaceuticals Key Product Overview
Table 57. Pocono Corporate Outline
Table 58. Pocono Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
Table 59. Pocono Key Product Overview
Table 60. DURECT Corporation Corporate Outline
Table 61. DURECT Corporation Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
Table 62. DURECT Corporation Key Product Overview
Table 63. Xel Pharmaceuticals Corporate Outline
Table 64. Xel Pharmaceuticals Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
Table 65. Xel Pharmaceuticals Key Product Overview
 
List of Figures
Figure 1. Product Picture of Transdermal Drug Patches
Figure 2. Proportion of GDP of Major Countries in the World in 2018
Figure 3. Figure Projected Growth Profiles for Major Economies – Regression to the Mean
Figure 4. Figure Key Economies’ Share of World GDP in PPP Terms
Figure 5. Global Economic Forecast in 2050
Figure 6. Global GDP Forecast by Region to 2050
Figure 7. Climate Change Impact on Level of GDP in 2050
Figure 8. Economic Impact of COVID-19 on Major Economies in 2020
Figure 9. IMF's Latest Global Economic Forecast by 2021Q1
Figure 10. Comparative Analysis of the Direct Impact of COVID-19 on the Industry (US$ Million)
Figure 11. Characteristics of the Impact of COVID-19 on the Industry
Figure 12. Key Players Revenue Volume Share in 2020
Figure 13. Global Transdermal Drug Patches Revenue Share by Manufacturers in 2020
Figure 14. Market Size Share Comparison by End User
Figure 15. Global Transdermal Drug Patches Market Size by Region in 2020
Figure 16. Global Transdermal Drug Patches Market Size by Region: 2016 VS 2020 VS 2027
Figure 17. Global Transdermal Drug Patches Market Size 2016-2027 (US$ Million)
Figure 18. Global Transdermal Drug Patches Market Size 2016-2027 (US$ Million)
Figure 19. 2016-2027 Global Segment: Transdermal Drug Patches Sales Volume Market Share, by Region
Figure 20. 2016-2027 Global Segment: Transdermal Drug Patches Revenue Market Share, by Region
Figure 21.  North America Transdermal Drug Patches Key Player Distribution Analysis
Figure 22. North America Transdermal Drug Patches Revenue Market Share in 2020, by Country (% Share)
Figure 23. Europe Transdermal Drug Patches Key Player Distribution Analysis
Figure 24. Europe Transdermal Drug Patches Revenue Market Share in 2020, by Country (% Share)
Figure 25. Asia Pacific Transdermal Drug Patches Key Player Distribution Analysis
Figure 26. Asia Pacific Transdermal Drug Patches Revenue Market Share in 2020, by Country (% Share)
Figure 27.  South America Transdermal Drug Patches Key Player Distribution Analysis
Figure 28. South America Transdermal Drug Patches Revenue Market Share in 2020, by Country (% Share)
Figure 29.  Middle East and Africa Transdermal Drug Patches Key Player Distribution Analysis
Figure 30. Transdermal Drug Patches Industry SWOT Analysis
Figure 31. Figure Marketing Strategy
Figure 32. Transdermal Drug Patches Technology Development Trend
Figure 33. Global Stars: The Most Innovative Countries, Ranked by Income Group in 2019
Figure 34. Leading countries by gross research and development (R&D) expenditure worldwide in 2020(in billion U.S. dollars)
Figure 35. Transdermal Drug Patches Industrial Chain Analysis
Figure 36. FDI, trade, GDP and GVC trends, 1990–2019
Figure 37. World Carbon Dioxide Emissions from 2009 to 2019, by region (in Million Metric Tons of Carbon Dioxide)
Figure 38. Global Energy Structure Evolution Structure
Figure 39. The Evolution of Global Road Vehicles to 2050
Figure 40. Noven SWOT Analysis
Figure 41. Mylan SWOT Analysis
Figure 42. Novartis SWOT Analysis
Figure 43. Johnson & Johnson SWOT Analysis
Figure 44. Agile Therapeutics SWOT Analysis
Figure 45. Teikoku Pharma USA SWOT Analysis
Figure 46. Immune Pharmaceuticals SWOT Analysis
Figure 47. Hercon Pharmaceuticals SWOT Analysis
Figure 48. Pocono SWOT Analysis
Figure 49. DURECT Corporation SWOT Analysis
Figure 50. Xel Pharmaceuticals SWOT Analysis
 

ASSO regards each project as the best communication bridge between us and our customers. ASSO solemnly promises that ASSO will treat each project as our most important customer project. We will go all out and never give up. ASSO regards each other's excellence as the purpose of our service. ASSO's services involve regional analysis, market data, player share, market decision-making, marketing and product positioning

– Allen King

Leave a comment

All fields marked with an asterisk (*) are required